Literature DB >> 33547280

Impaired eIF5A function causes a Mendelian disorder that is partially rescued in model systems by spermidine.

Víctor Faundes1,2, Martin D Jennings3,4, Siobhan Crilly5, Sarah Legraie1, Sarah E Withers5, Sara Cuvertino1, Sally J Davies6, Andrew G L Douglas7,8, Andrew E Fry6,9, Victoria Harrison7, Jeanne Amiel10,11,12, Daphné Lehalle10, William G Newman1,13, Patricia Newkirk14, Judith Ranells14, Miranda Splitt15, Laura A Cross16,17, Carol J Saunders18,19,20, Bonnie R Sullivan16,17, Jorge L Granadillo21, Christopher T Gordon11,12, Paul R Kasher22,23, Graham D Pavitt24,25, Siddharth Banka26,27.   

Abstract

The structure of proline prevents it from adopting an optimal position for rapid protein synthesis. Poly-proline-tract (PPT) associated ribosomal stalling is resolved by highly conserved eIF5A, the only protein to contain the amino acid hypusine. We show that de novo heterozygous EIF5A variants cause a disorder characterized by variable combinations of developmental delay, microcephaly, micrognathia and dysmorphism. Yeast growth assays, polysome profiling, total/hypusinated eIF5A levels and PPT-reporters studies reveal that the variants impair eIF5A function, reduce eIF5A-ribosome interactions and impair the synthesis of PPT-containing proteins. Supplementation with 1 mM spermidine partially corrects the yeast growth defects, improves the polysome profiles and restores expression of PPT reporters. In zebrafish, knockdown eif5a partly recapitulates the human phenotype that can be rescued with 1 µM spermidine supplementation. In summary, we uncover the role of eIF5A in human development and disease, demonstrate the mechanistic complexity of EIF5A-related disorder and raise possibilities for its treatment.

Entities:  

Year:  2021        PMID: 33547280      PMCID: PMC7864902          DOI: 10.1038/s41467-021-21053-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  72 in total

1.  Microdeletion in distal 17p13.1: a recognizable phenotype with microcephaly, distinctive facial features, and intellectual disability.

Authors:  Susan Zeesman; Susanne Kjaergaard; Hanne D Hove; Maria Kirchhoff; Jadd M Stevens; Małgorzata J M Nowaczyk
Journal:  Am J Med Genet A       Date:  2012-06-29       Impact factor: 2.802

2.  The Matchmaker Exchange: a platform for rare disease gene discovery.

Authors:  Anthony A Philippakis; Danielle R Azzariti; Sergi Beltran; Anthony J Brookes; Catherine A Brownstein; Michael Brudno; Han G Brunner; Orion J Buske; Knox Carey; Cassie Doll; Sergiu Dumitriu; Stephanie O M Dyke; Johan T den Dunnen; Helen V Firth; Richard A Gibbs; Marta Girdea; Michael Gonzalez; Melissa A Haendel; Ada Hamosh; Ingrid A Holm; Lijia Huang; Matthew E Hurles; Ben Hutton; Joel B Krier; Andriy Misyura; Christopher J Mungall; Justin Paschall; Benedict Paten; Peter N Robinson; François Schiettecatte; Nara L Sobreira; Ganesh J Swaminathan; Peter E Taschner; Sharon F Terry; Nicole L Washington; Stephan Züchner; Kym M Boycott; Heidi L Rehm
Journal:  Hum Mutat       Date:  2015-10       Impact factor: 4.878

Review 3.  A review of craniofacial disorders caused by spliceosomal defects.

Authors:  D Lehalle; D Wieczorek; R M Zechi-Ceide; M R Passos-Bueno; S Lyonnet; J Amiel; C T Gordon
Journal:  Clin Genet       Date:  2015-05-01       Impact factor: 4.438

4.  eIF5A promotes translation of polyproline motifs.

Authors:  Erik Gutierrez; Byung-Sik Shin; Christopher J Woolstenhulme; Joo-Ran Kim; Preeti Saini; Allen R Buskirk; Thomas E Dever
Journal:  Mol Cell       Date:  2013-05-30       Impact factor: 17.970

5.  Molecular insights into protein synthesis with proline residues.

Authors:  Sergey Melnikov; Justine Mailliot; Lukas Rigger; Sandro Neuner; Byung-Sik Shin; Gulnara Yusupova; Thomas E Dever; Ronald Micura; Marat Yusupov
Journal:  EMBO Rep       Date:  2016-11-08       Impact factor: 8.807

6.  Spermidine protects against α-synuclein neurotoxicity.

Authors:  Sabrina Büttner; Filomena Broeskamp; Cornelia Sommer; Maria Markaki; Lukas Habernig; Ali Alavian-Ghavanini; Didac Carmona-Gutierrez; Tobias Eisenberg; Eva Michael; Guido Kroemer; Nektarios Tavernarakis; Stephan J Sigrist; Frank Madeo
Journal:  Cell Cycle       Date:  2014       Impact factor: 5.173

7.  eIF5A facilitates translation termination globally and promotes the elongation of many non polyproline-specific tripeptide sequences.

Authors:  Vicent Pelechano; Paula Alepuz
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

8.  ACTB Loss-of-Function Mutations Result in a Pleiotropic Developmental Disorder.

Authors:  Sara Cuvertino; Helen M Stuart; Kate E Chandler; Neil A Roberts; Ruth Armstrong; Laura Bernardini; Sanjeev Bhaskar; Bert Callewaert; Jill Clayton-Smith; Cristina Hernando Davalillo; Charu Deshpande; Koenraad Devriendt; Maria C Digilio; Abhijit Dixit; Matthew Edwards; Jan M Friedman; Antonio Gonzalez-Meneses; Shelagh Joss; Bronwyn Kerr; Anne Katrin Lampe; Sylvie Langlois; Rachel Lennon; Philippe Loget; David Y T Ma; Ruth McGowan; Maryse Des Medt; James O'Sullivan; Sylvie Odent; Michael J Parker; Céline Pebrel-Richard; Florence Petit; Zornitza Stark; Sylvia Stockler-Ipsiroglu; Sigrid Tinschert; Pradeep Vasudevan; Olaya Villa; Susan M White; Farah R Zahir; Adrian S Woolf; Siddharth Banka
Journal:  Am J Hum Genet       Date:  2017-12-07       Impact factor: 11.025

9.  Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome.

Authors:  Alexander A Morgan; Edward Rubenstein
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  Exaggerated translation causes synaptic and behavioural aberrations associated with autism.

Authors:  Emanuela Santini; Thu N Huynh; Andrew F MacAskill; Adam G Carter; Philippe Pierre; Davide Ruggero; Hanoch Kaphzan; Eric Klann
Journal:  Nature       Date:  2012-12-23       Impact factor: 49.962

View more
  6 in total

1.  Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder.

Authors:  Alban Ziegler; Katharina Steindl; Ashleigh S Hanner; Rajesh Kumar Kar; Clément Prouteau; Anne Boland; Jean Francois Deleuze; Christine Coubes; Stéphane Bézieau; Sébastien Küry; Isabelle Maystadt; Morgane Le Mao; Guy Lenaers; Benjamin Navet; Laurence Faivre; Frédéric Tran Mau-Them; Paolo Zanoni; Wendy K Chung; Anita Rauch; Dominique Bonneau; Myung Hee Park
Journal:  Am J Hum Genet       Date:  2022-07-19       Impact factor: 11.043

2.  Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome.

Authors:  Mukund P Tantak; Vandana Sekhar; Xianzun Tao; R Grace Zhai; Otto Phanstiel
Journal:  J Med Chem       Date:  2021-10-25       Impact factor: 8.039

Review 3.  Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia.

Authors:  Emily Connell; Gwenaelle Le Gall; Matthew G Pontifex; Saber Sami; John F Cryan; Gerard Clarke; Michael Müller; David Vauzour
Journal:  Mol Neurodegener       Date:  2022-06-17       Impact factor: 18.879

4.  Overlapping regions of Caf20 mediate its interactions with the mRNA-5'cap-binding protein eIF4E and with ribosomes.

Authors:  Ebelechukwu C Nwokoye; Eiman AlNaseem; Robert A Crawford; Lydia M Castelli; Martin D Jennings; Christopher J Kershaw; Graham D Pavitt
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 5.  The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles.

Authors:  Michel Tauc; Marc Cougnon; Romain Carcy; Nicolas Melis; Thierry Hauet; Luc Pellerin; Nicolas Blondeau; Didier F Pisani
Journal:  Cell Biosci       Date:  2021-12-24       Impact factor: 7.133

Review 6.  Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.

Authors:  Myung Hee Park; Rajesh Kumar Kar; Siddharth Banka; Alban Ziegler; Wendy K Chung
Journal:  Amino Acids       Date:  2021-07-17       Impact factor: 3.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.